Broward County Commission Regular Meeting
Director's Name: Andrew J. Meyers
Department: County Attorney
Information
Requested Action
title
MOTION TO APPROVE Participation Agreement regarding opioid litigation in substantially the same form as Exhibit 1; and to authorize the County Administrator to execute the Participation Agreement with any required modifications, provided such modifications do not impose any additional, material financial risk on the County, and subject to review and approval as to legal sufficiency by the County Attorney's Office.
body
Why Action is Necessary
Approval is required by the Board of County Commissioners ("Board") to resolve the County's pending claims against Purdue Pharma L.P., et al. ("Purdue Pharma"), and the Sackler family, majority shareholders of Purdue Pharma (collectively, "Defendants").
What Action Accomplishes
Allows the Board to approve the Participation Agreement which, as part of the global settlement involving Purdue Pharma, would settle and release the County's opioid claims against Purdue Pharma.
Goal Related Icon(s)
?County Commission
?Go Green
?MAP Broward
Previous Action Taken
Summary Explanation/Background
On December 12, 2017, the Board authorized the filing of litigation against manufacturers, distributors, and other potential parties in connection with the opioid epidemic. On March 12, 2018, Broward County filed a multicount lawsuit against multiple manufacturers (including Purdue Pharma), distributors, and marketers of opioids.
On September 15, 2019, Purdue Pharma filed for Chapter 11 bankruptcy protection. In October 2019 Broward County joined an ad hoc unsecured creditor's committee to negotiate settlement on behalf of government parties that sued Purdue Pharma.
On September 21, 2021, the Board adopted Resolution No. 202-464 (Item No. 51), which approved the Florida Opioid Allocation and Statewide Response Agreement (the "Florida Plan"). The Florida Plan provided the framework...
Click here for full text